Quantcast
Last updated on April 18, 2014 at 6:49 EDT

Latest epinephrine Stories

2010-12-23 06:00:00

BASKING RIDGE, N.J., Dec. 23, 2010 /PRNewswire-FirstCall/ -- Dey Pharma, L.P. today announced that it has signed a license agreement with Meda, a leading international specialty pharma company headquartered in Sweden, for the exclusive marketing and distribution rights of EpiPen® (epinephrine) Auto-Injector in Europe. EpiPen Auto-Injector is used for emergency treatment of severe allergic reactions (anaphylaxis). Anaphylaxis can occur quickly, often within a couple of...

2010-09-14 06:57:00

SILICON VALLEY, Calif., Sept. 14 /PRNewswire/ -- Mediaspectrum, Inc.® today introduced Adrenalin, the first complete solution for publishers seeking to create a customized news-reading application for Apple's iPad and other tablet devices. Adrenalin powers the three pillars of every digital news organization--dynamic content, integrated advertising, and subscription management--and offers publishers a low-risk, low-cost opportunity to establish a powerful presence in the...

2010-07-01 07:20:00

BLUFFTON, S.C., July 1 /PRNewswire/ -- In the last 15 years, allergist Thomas C. Beller, M.D., founder of TCB Medical Devices (http://www.tcbmedicaldevices.com), has seen a relative allergy epidemic. Seasonal allergies, asthma, eczema and atopic dermatitis have all increased dramatically -- but the most dramatic surge has been in food-, medicine- and insect-related anaphylaxis. Wanting to make it easier for allergy sufferers to keep epinephrine close at hand, Beller developed a better...

2010-06-25 16:13:01

We've all experienced the strong heartbeat that accompanies emotions such as fear and rage. But can the body's natural response to these emotions be used to combat heart failure? Results of a study published online today in the journal Circulation Research present a strong case. In the study, scientists from the University of Rochester Medical Center found that two experimental drugs have the potential to restore pumping strength to failing hearts in part by harnessing the fight-or-flight...

2010-02-25 15:08:55

Researchers have been able to see how heart failure affects the surface of an individual heart muscle cell in minute detail, using a new nanoscale scanning technique developed at Imperial College London. The findings may lead to better design of beta-blockers, the drugs that can slow the development of heart failure, and to improvements in current therapeutic approaches to treating heart failure and abnormal heart rhythms. Heart failure is a progressive and serious condition in which the...

2010-02-16 14:30:00

NEW YORK, Feb. 16 /PRNewswire/ -- The Partnership for a Drug-Free America and Adrenalina, a leading multicultural advertising and marketing agency that is part of the MDC Partners network, said today the two groups have joined forces to create a non-profit Spanish-language multimedia public service campaign aimed at Hispanic families. Adrenalina will provide the Partnership with creative and strategic counsel on reaching Hispanic parents about preventing drug use among Latino youth via a...

2009-11-30 07:30:00

RICHMOND, Va., Nov. 30 /PRNewswire/ -- Intelliject, Inc. today announced an exclusive license with sanofi-aventis U.S. for a novel epinephrine auto-injector, in the U.S. and Canada territory. Under the license, sanofi-aventis U.S. shall be responsible for manufacturing and commercialization. Intelliject will be responsible for the on-going development and for obtaining U.S. regulatory approval and has retained certain co-promotion rights in the territory. Sanofi-aventis U.S. will pay an...

2009-11-30 07:30:00

BRIDGEWATER, N.J., Nov. 30 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today the signing of an exclusive licensing agreement with Intelliject, Inc. for a novel epinephrine auto injector for the emergency treatment of allergic reactions (anaphylaxis) in North America (U.S. and Canada). "We are pleased to have this opportunity to offer this innovative delivery device for the millions of people who are at risk of this life-threatening allergic reaction each year," stated Brent...

2009-11-24 18:10:30

Patients with an out-of-hospital cardiac arrest who received intravenous (IV) drug administration during treatment, recommended in life support guidelines, had higher rates of short term survival but no statistically significant improvement in survival to hospital discharge or long-term survival, compared to patients who did not receive IV drug administration, according to a study in the November 25 issue of JAMA. "Intravenous access and drug administration are integral parts of...

2009-11-16 13:00:00

NEW YORK, Nov. 16 /PRNewswire/ -- Seeking to infuse its digital innovation strategy with a dose of real-world perspective, Adrenalina, a leading multicultural advertising and marketing agency that is part of the MDC Partners network, said today it is mounting a next-generation multicultural micro site aimed at unleashing the power and influence of U.S. Hispanic and African Americans. Dubbed TheCountThatCounts.com, the micro site serves to buoy the GetAdrenalina.com portal with Web 2.0...